---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-096548"
form_type: "8-K"
ticker: "NMTC"
cik: "0001500198"
company_name: "NEUROONE MEDICAL TECHNOLOGIES Corp"
filed_at: "2025-10-06T23:59:59+00:00"
generated_at: "2026-05-17T04:33:59.069855+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NeuroOne reports preliminary FY2025 product revenue of $9.1M, up 163% from $3.5M in FY2024

## Summary
- Preliminary unaudited FY2025 product revenue $9.1M, a record; FY2024 was $3.5M.
- Cash and equivalents $6.6M as of September 30, 2025.
- Growth driven by expanded customer interest in OneRF Ablation system for epilepsy.
- Complete financial results expected to be announced in December 2025.
- Company to host virtual investor webinar on October 7, 2025 at 8:30am EST.

## SEC filing metadata
- accession: 0001213900-25-096548
- form_type: 8-K
- ticker: NMTC
- cik: 0001500198
- company_name: NEUROONE MEDICAL TECHNOLOGIES Corp
- filed_at: 2025-10-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1500198/000121390025096548/0001213900-25-096548-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1500198/000121390025096548/ea0260404-8k_neuroone.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-096548
- JSON: https://secwatch.observer/filing/0001213900-25-096548.json
- Plain text: https://secwatch.observer/filing/0001213900-25-096548.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.